Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cariou

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Diabetes & Metabolism|February 7, 2009
The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitisB Cariou
Diabetes & Metabolism|January 17, 2016
Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the associationB Cariou
Diabetes & Metabolism|June 8, 2012
Harnessing the incretin system beyond glucose control: potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetesB Cariou
La Revue Du Praticien|December 6, 2011
[Screening for familial hypercholesterolemia]B Cariou, M Krempf
Diabetes, Obesity & Metabolism|January 5, 2011
Pharmacological management of type 2 diabetes: the potential of incretin-based therapiesB Charbonnel, B Cariou
Diabetes & Metabolism|December 3, 2014
Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: A case seriesB Cariou, C Bernard, D Cantarovich
Annales De Chirurgie|April 26, 2005
[Bilateral pheochromocytoma. Genetics and treatment]E Mirallié, B Cariou, F Kraeber-Bodéré
Diabetes & Metabolism|August 7, 2018
Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathwaysM Joubert, A Manrique, B Cariou, et al.
Presse Medicale (Paris, France : 1983)|November 10, 2000
[Cutaneous metastases from follicular thyroid cancer]B Cariou, B Charbonnel, M F Heymann, et al.
Diabetes, Nutrition & Metabolism|August 30, 2000
Angiographic characteristics of coronary artery disease in diabetic patients compared with matched non-diabetic subjectsB Cariou, L Bonnevie, H Mayaudon, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Diabetes & Metabolism|February 7, 2009
The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitisB Cariou
Diabetes & Metabolism|January 17, 2016
Pleiotropic effects of insulin and GLP-1 receptor agonists: Potential benefits of the associationB Cariou
Diabetes & Metabolism|June 8, 2012
Harnessing the incretin system beyond glucose control: potential cardiovascular benefits of GLP-1 receptor agonists in type 2 diabetesB Cariou
La Revue Du Praticien|December 6, 2011
[Screening for familial hypercholesterolemia]B Cariou, M Krempf
Diabetes, Obesity & Metabolism|January 5, 2011
Pharmacological management of type 2 diabetes: the potential of incretin-based therapiesB Charbonnel, B Cariou
Diabetes & Metabolism|December 3, 2014
Liraglutide in whole-pancreas transplant patients with impaired glucose homoeostasis: A case seriesB Cariou, C Bernard, D Cantarovich
Annales De Chirurgie|April 26, 2005
[Bilateral pheochromocytoma. Genetics and treatment]E Mirallié, B Cariou, F Kraeber-Bodéré
Diabetes & Metabolism|August 7, 2018
Diabetes-related cardiomyopathy: The sweet story of glucose overload from epidemiology to cellular pathwaysM Joubert, A Manrique, B Cariou, et al.
Presse Medicale (Paris, France : 1983)|November 10, 2000
[Cutaneous metastases from follicular thyroid cancer]B Cariou, B Charbonnel, M F Heymann, et al.
Diabetes, Nutrition & Metabolism|August 30, 2000
Angiographic characteristics of coronary artery disease in diabetic patients compared with matched non-diabetic subjectsB Cariou, L Bonnevie, H Mayaudon, et al.
Pageof 5